160 related articles for article (PubMed ID: 11936867)
1. In vitro-prepared advanced glycation end-products and the modulating potential of their low-molecular weight degradation products in IRPTC-A rat proximal-tubular derived kidney epithelial cell line.
Deuther-Conrad W; Franke S; Henle T; Sommer M; Stein G
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL187-96. PubMed ID: 11936867
[TBL] [Abstract][Full Text] [Related]
2. Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteins.
Deuther-Conrad W; Franke S; Sommer M; Henle T; Stein G
Kidney Int Suppl; 2001 Feb; 78():S63-6. PubMed ID: 11168985
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1.
Sebeková K; Schinzel R; Ling H; Simm A; Xiang G; Gekle M; Münch G; Vamvakas S; Heidland A
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1051-60. PubMed ID: 9846887
[TBL] [Abstract][Full Text] [Related]
4. Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin.
Ozdemir AM; Hopfer U; Rosca MV; Fan XJ; Monnier VM; Weiss MF
Am J Nephrol; 2008; 28(1):14-24. PubMed ID: 17890854
[TBL] [Abstract][Full Text] [Related]
5. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.
Yamagishi S; Inagaki Y; Okamoto T; Amano S; Koga K; Takeuchi M
Kidney Int; 2003 Feb; 63(2):464-73. PubMed ID: 12631112
[TBL] [Abstract][Full Text] [Related]
7. Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy.
Ozdemir AM; Hopfer U; Erhard P; Monnier VM; Weiss MF
Ann N Y Acad Sci; 2005 Jun; 1043():625-36. PubMed ID: 16037286
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.
Gallicchio MA; McRobert EA; Tikoo A; Cooper ME; Bach LA
J Am Soc Nephrol; 2006 Feb; 17(2):414-21. PubMed ID: 16371434
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-products induce calpain-mediated degradation of ezrin.
McRobert EA; Young AN; Bach LA
FEBS J; 2012 Sep; 279(17):3240-50. PubMed ID: 22805611
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
11. Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis.
Gallicchio MA; Bach LA
Biochim Biophys Acta; 2013 Dec; 1833(12):2922-2932. PubMed ID: 23747564
[TBL] [Abstract][Full Text] [Related]
12. Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases.
Saito A; Takeda T; Sato K; Hama H; Tanuma A; Kaseda R; Suzuki Y; Gejyo F
Ann N Y Acad Sci; 2005 Jun; 1043():637-43. PubMed ID: 16037287
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages.
Pertyńska-Marczewska M; Kiriakidis S; Wait R; Beech J; Feldmann M; Paleolog EM
Cytokine; 2004 Oct; 28(1):35-47. PubMed ID: 15341924
[TBL] [Abstract][Full Text] [Related]
15. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy.
Chibber R; Molinatti PA; Rosatto N; Lambourne B; Kohner EM
Diabetologia; 1997 Feb; 40(2):156-64. PubMed ID: 9049475
[TBL] [Abstract][Full Text] [Related]
16. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.
Kowluru RA
Life Sci; 2005 Jan; 76(9):1051-60. PubMed ID: 15607333
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells.
Stitt AW; He C; Vlassara H
Biochem Biophys Res Commun; 1999 Mar; 256(3):549-56. PubMed ID: 10080935
[TBL] [Abstract][Full Text] [Related]
18. Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE.
Nakano N; Fukuhara-Takaki K; Jono T; Nakajou K; Eto N; Horiuchi S; Takeya M; Nagai R
J Biochem; 2006 May; 139(5):821-9. PubMed ID: 16751589
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end product (AGE): characterization of the products from the reaction between D-glucose and serum albumin.
Wu JT; Tu MC; Zhung P
J Clin Lab Anal; 1996; 10(1):21-34. PubMed ID: 8926563
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).
Oldfield MD; Bach LA; Forbes JM; Nikolic-Paterson D; McRobert A; Thallas V; Atkins RC; Osicka T; Jerums G; Cooper ME
J Clin Invest; 2001 Dec; 108(12):1853-63. PubMed ID: 11748269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
